292 related articles for article (PubMed ID: 16406033)
21. Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease.
Lin WR; Shang D; Itzhaki RF
Mol Chem Neuropathol; 1996; 28(1-3):135-41. PubMed ID: 8871952
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E in the brain and its role in Alzheimer's disease.
Poirier J
J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
[TBL] [Abstract][Full Text] [Related]
23. Lipid metabolism in cognitive decline and dementia.
Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
[TBL] [Abstract][Full Text] [Related]
24. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus?
Wozniak MA; Shipley SJ; Dobson CB; Parker SP; Scott FT; Leedham-Green M; Breuer J; Itzhaki RF
Eur J Hum Genet; 2007 Jun; 15(6):672-8. PubMed ID: 17356546
[TBL] [Abstract][Full Text] [Related]
25. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
26. Lipoproteins and lipid peroxidation in Alzheimer's disease.
Bassett CN; Montine TJ
J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
[TBL] [Abstract][Full Text] [Related]
27. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
28. Fatty acids, lipid metabolism and Alzheimer pathology.
Hooijmans CR; Kiliaan AJ
Eur J Pharmacol; 2008 May; 585(1):176-96. PubMed ID: 18378224
[TBL] [Abstract][Full Text] [Related]
29. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
[TBL] [Abstract][Full Text] [Related]
30. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
Carter CJ
Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
[TBL] [Abstract][Full Text] [Related]
32. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease.
Mori I; Kimura Y; Naiki H; Matsubara R; Takeuchi T; Yokochi T; Nishiyama Y
J Med Virol; 2004 Aug; 73(4):605-11. PubMed ID: 15221907
[TBL] [Abstract][Full Text] [Related]
34. Traumatic brain injury and Alzheimer's disease: a review.
Van Den Heuvel C; Thornton E; Vink R
Prog Brain Res; 2007; 161():303-16. PubMed ID: 17618986
[TBL] [Abstract][Full Text] [Related]
35. Challenges and directions for the pathogen hypothesis of Alzheimer's disease.
Robinson SR; Dobson C; Lyons J
Neurobiol Aging; 2004; 25(5):629-37. PubMed ID: 15172741
[TBL] [Abstract][Full Text] [Related]
36. Androgens, apoE, and Alzheimer's disease.
Raber J
Sci Aging Knowledge Environ; 2004 Mar; 2004(11):re2. PubMed ID: 15028864
[TBL] [Abstract][Full Text] [Related]
37. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
38. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
39. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
40. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
